Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.
Researchers at UC San Diego School of Medicine use bacteriotherapy to improve symptoms of atopic dermatitis.
UC San Diego physicists are discovering details about the fundamental properties of exotic particles known as excitons. Their findings include pinpointing a visual phenomenon tied to a new state of matter as well as the first confirmation of exciton superfluidity.
The Qualcomm Institute at the University of California San Diego has appointed the composer, music professor and sound designer Shahrokh Yadegari to be an Associate Director of the interdisciplinary institute.
UC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
